Laidlaw Wealth Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,808
Closed -$207K 247
2023
Q4
$207K Buy
+1,808
New +$180K 0.08% 226
2023
Q3
Sell
-1,808
Closed -$204K 380
2023
Q2
$204K Buy
+1,808
New +$191K 0.04% 326
2023
Q1
Sell
-1,886
Closed -$209K 379
2022
Q4
$209K Buy
+1,886
New +$198K 0.04% 330
2022
Q1
Sell
-1,966
Closed -$236K 431
2021
Q4
$236K Buy
1,966
+28
+1% +$3.48K 0.04% 355
2021
Q3
$240K Buy
1,938
+131
+7% +$16.9K 0.06% 214
2021
Q2
$217K Buy
+1,807
New +$206K 0.06% 237

Other funds holding XYL

Laidlaw Wealth Management's XYL Position: Q1 2024 in Review

Laidlaw Wealth Management sold out of Xylem (XYL) in Q1 2024, closing a stake of 1,808 shares — an estimated $207K sold.

Laidlaw Wealth Management first reported a position in XYL in Q2 2021 and held it in 6 quarters. The position peaked at $240K in Q3 2021. 987 funds tracked by Wall St. Rank hold XYL as of Q1 2024.

  • Laidlaw Wealth Management reported no remaining Xylem position as of Q1 2024 after selling out during the quarter.
  • Laidlaw Wealth Management sold 1,808 Xylem shares in Q1 2024, an estimated $207K.
  • Laidlaw Wealth Management first reported a position in Xylem in Q2 2021 and held it in 6 quarters.
  • Laidlaw Wealth Management's Xylem position peaked at $240K in Q3 2021.
  • 987 funds tracked by Wall St. Rank held Xylem as of Q1 2024.

Based on Laidlaw Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.